Changes in plasma levels of hepatocyte growth factor and its associated factors during pregnancy

Journal of Obstetrics and Gynaecology Research

Volumn 32, Issue 1, 2006, Pages 10-14

  Watanabe, Takashi ^a   Sakata, Yoichi ^a   Matsubara, Shigeki ^a   Yamagishi, Toshiya ^b   Nagaike, Kazuhiro ^b   Kuwata, Tomoyuki ^a   Suzuki, Mitsuaki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b MITSUBISHI CHEMICAL CORPORATION   (Japan)

Author keywords

Hepatocyte growth factor; Hepatocyte growth factor activator; Hepatocyte growth factor activator inhibitor; Pregnancy

Indexed keywords

MITOGENIC AGENT; PROTEIN; PROTEIN PRECURSOR; SCATTER FACTOR; SCATTER FACTOR ACTIVATOR; SCATTER FACTOR ACTIVATOR INHIBITOR TYPE 1; SCATTER FACTOR ACTIVATOR INHIBITOR TYPE 2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; NORMAL HUMAN; PREGNANCY; PROTEIN BLOOD LEVEL; PUERPERIUM;

ADULT; CASE-CONTROL STUDIES; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; MEMBRANE GLYCOPROTEINS; PREGNANCY; SERINE ENDOPEPTIDASES; TRYPSIN INHIBITOR, KUNITZ SOYBEAN;

EID: 33645236763     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2006.00346.x     Document Type: Article

References (22)

1. Nakamura T Nawa K Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984 122 1450 1459.
2. Miyazawa K Shimomura T Kitamura N. Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator. J Biol Chem 1996 271 3615 3618.
3. Miyazawa K Shimomura T Naka D Kitamura N. Proteolytic activation of hepatocyte growth factor in response to tissue injury. J Biol Chem 1994 269 8966 8970.
4. Bottaro DP Rubin JS Faletto DL et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991 251 802 804.
5. Shimomura T Kondo J Ochiai M et al. Activation of the zymogen of hepatocyte growth factor activator by thrombin. J Biol Chem 1993 268 22927 22932.
6. Shimomura T Denda K Kitamura A et al. Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor. J Biol Chem 1997 272 6370 6376.
7. Kawaguchi T Qin L Shimomura T et al. Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor. J Biol Chem 1997 272 27558 27564.
8. Uehara Y Minowa O Mori CT et al. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 1995 373 702 705.
9. Horibe N Okamoto T Itakura A et al. Levels of hepatocyte growth factor in maternal serum and amniotic fluid. Am J Obstet Gynecol 1995 173 937 942.
10. Clark DE Salvig JD Smith SK Charnock-Jones DS. Hepatocyte growth factor levels during normal and intra-uterine growth-restricted pregnancies. Placenta 1998 19 671 673.
11. Iioka H. Clinical use of human hepatocyte growth factor in the early detection of HELLP syndrome. Gynecol Obstet Invest 1996 41 103 105.
12. Yoshiyama Y Arakaki N Naka D et al. Identification of the N-terminal residue of the heavy chain of both native and recombinant human hepatocyte growth factor. Biochem Biophys Res Commun 1991 175 660 667.
13. Arakaki N Kawakami S Nakamura O et al. Evidence for the presence of an inactive precursor of human hepatocyte growth factor in plasma and sera of patients with liver disease. Hepatology 1995 22 1728 1734.
14. Shimomura T Ochiai M Kondo J Morimoto Y. A novel protease obtained from FBS-containing culture supernatant, that processes single chain form hepatocyte growth factor to two chain form in serum-free culture. Cytotechnology 1992 8 219 229.
15. Shimomura T Denda K Kawaguchi T Matsumoto K Miyazawa K Kitamura N. Multiple sites of proteolytic cleavage to release soluble forms of hepatocyte growth factor activator inhibitor type 1 from a transmembrane form. J Biochem 1999 126 821 828.
16. Kataoka H Itoh H Uchino H et al. Conserved expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin in human colorectal carcinomas. Cancer Lett 2000 148 127 134.
17. Toglia MR Weg JG. Venous thromboembolism during pregnancy. N Engl J Med 1996 335 108 113.
18. Uszynski M. Generation of thrombin in blood plasma of non-pregnant and pregnant women studied through concentration of thrombin-antithrombin III complexes. Eur J Obstet Gynecol Reprod Biol 1997 75 127 131.
19. Kataoka H Meng JY Itoh H et al. Localization of hepatocyte growth factor activator inhibitor type 1 in Langhans' cells of human placenta. Histochem Cell Biol 2000 114 469 475.
20. Simpson RA Mayhew TM Barnes PR. From 13 weeks to term, the trophoblasts of human placenta grows by the continuous recruitment of new proliferative units: A study of nuclear number using the dissector. Placenta 1992 13 501 512.
21. Furugori K Kurauchi O Itakura A et al. Levels of hepatocyte growth factor and its messenger ribonucleic acid in uncomplicated pregnancies and those complicated by preeclampsia. J Clin Endocrinol Metab 1997 82 2726 2730.
22. Aoki S Hata T Manabe A Miyazaki K. Decreased maternal circulating hepatocyte growth factor (HGF) concentrations in pregnancies with small for gestational age infants. Hum Reprod 1998 13 2950 2953.